News
Current position:Product Center > Cell lines > Cytokines > TGF-β > BRE Reporter 293 Cell Line
BRE Reporter 293 Cell Line
Description
Cat. No: GM-C37665
Product: BRE Reporter 293 Cell Line


Bone Morphogenetic Proteins (BMPs) are important members of the Transforming Growth Factor-β (TGF-β) superfamily, initially discovered for their role in bone and cartilage formation. The BMP signaling pathway plays a critical role in various biological processes, including embryonic development, cell differentiation, proliferation, apoptosis, as well as tissue regeneration and repair.

BRE Reporter 293 Cell Line is a clonal stable cell line with signal-dependent expression of a luciferase reporter gene stably transfected with the BMP Response Element (BRE) using lentiviral technology, and it endogenously expresses Type I Reporter and Type II Reporter gene. When ligands such as BMP-2 bind to their receptors, they activate downstream signaling pathways, which subsequently drive the expression of luciferase. By measuring the fluorescence signal, the expression of luciferase can be determined, indirectly evaluating the effect of the ligand on the signaling pathway. The luciferase readout represents the activation level of the signaling pathway. Therefore, this cell line is widely used for the screening of BMP ligands, receptor agonists, or inhibitors, as well as for studying the regulatory mechanisms of the signaling pathway.
Data
Response to Recombinant Human, Mouse, Rat, Rhesus, Canine BMP-2 Protein. BRE Reporter 293 Cell Line (Cat. GM-C37665) at a concentration of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Recombinant BMP-2 Protein (Sino Biological/10426-HNAE) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). The maximum induction fold was approximately [8.9]. Data are shown by drug mass concentration.
Response to Anti-ACVR2B hIgG1 Antibody(Bimagrumab). Serial dilutions of the Anti-ACVR2B hIgG1 Antibody(Bimagrumab) (Cat. GM-51148AB) was incubated with 1.5E4 cells/well of the BRE Reporter 293 Cell Line (Cat. GM-C37665) in a 96-well plate for 1 hour in assay buffer (DMEM + 1% FBS + 1% P.S). Subsequently, the BMP-2 Protein (Sino Biological/10426-HNAE) at a concentration of 27 ng/well was added, and the coculture proceeded for an additional 6 hours. Firefly luciferase activity is then measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). The results indicated maximum blocking folds of approximately [2.9]. Data are shown by drug mass concentration.
The passage stability of response to Recombinant BMP-2 Protein. The passage 4, 14, and 24 of BRE Reporter 293 Cell Line (Cat. GM-C37665) at a concentration of 1.5E4 cells/well (96-well format) were stimulated with serial dilutions of Recombinant BMP-2 Protein (Sino Biological/10426-HNAE) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). Data are shown by drug mass concentration.
Response to ligand protein. The BRE Reporter 293 Cell Line (Cat. GGM-C37665) at a concentration of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Human GDF-2 Protein (ACRO/GD2-H5211), Human Activin A Protein (Cat. GM-87616RP) and Human latent GDF-8 Protein(Cat. GM-87733RP) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). Data are shown by drug mass concentration.
BRE Reporter 293 Cell Line (Cat. GM-C37665) was determined by flow cytometry using Anti-ACVR2B hIgG1 Antibody(Bimagrumab) (Cat. GM-51148AB).
Specifications
Cat. NoGM-C37665
ProductBRE Reporter 293 Cell Line
Product Format1 vial of frozen cells
Quantity5E6 Cells per vail,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumDMEM+10% FBS+1% P.S
Growth mediumDMEM+10% FBS+1% P.S+4 μg/mL Blasticidin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
DMEMGibco/C11995500BT
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
Blasticidin
Recombinant Human, Mouse, Rat, Rhesus, Canine BMP-2 ProteinSino Biological/10426-HNAE
Human GDF-2 Protein, Tag FreeACRO/GD2-H5211
Human Activin A Protein; His Tag
Human latent GDF-8 Protein; His Tag
Anti-ACVR2B hIgG1 Antibody(Bimagrumab)
GMOne-Step Luciferase Reporter Gene Assay Kit
Cell Culture

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+4 μg/mL Blasticidin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Subculturing is necessary when the cell density reaches 80%. It is recommended to perform subculturing at a ratio of 1:3 to 1:4 every 2-3 days. Ensure that the density does not exceed 80%, as overcrowding can lead to reduced viability due to compression.

b)         Remove and discard culture medium.

c)          Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

d)         Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

e)          Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

f)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

g)         After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

h)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial thawing, a higher number of dead cells is observed, which is a normal phenomenon. Significant improvement is seen after adaptation. Once the cells reach a stable state, the number of dead cells decreases after subculturing and the cell growth rate becomes stable.

b)         Ensure that the cell density does not exceed 80%, as overcrowding may lead to reduced viability due to compression.

Related Products
Get A Quote
GCGR


GLP1R



FGF21:FGFR


CALCA(CGRP):CALCRL RAMP



GIP:GIPR




ACVR2A:ACTRIIB:Active A



AMY:CALCR RAMP

Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Current Position:Product Center > Cell lines > Cytokines > TGF-β > BRE Reporter 293 Cell Line
classify
BRE Reporter 293 Cell Line
Description
Cat. No: GM-C37665
Product: BRE Reporter 293 Cell Line


Bone Morphogenetic Proteins (BMPs) are important members of the Transforming Growth Factor-β (TGF-β) superfamily, initially discovered for their role in bone and cartilage formation. The BMP signaling pathway plays a critical role in various biological processes, including embryonic development, cell differentiation, proliferation, apoptosis, as well as tissue regeneration and repair.

BRE Reporter 293 Cell Line is a clonal stable cell line with signal-dependent expression of a luciferase reporter gene stably transfected with the BMP Response Element (BRE) using lentiviral technology, and it endogenously expresses Type I Reporter and Type II Reporter gene. When ligands such as BMP-2 bind to their receptors, they activate downstream signaling pathways, which subsequently drive the expression of luciferase. By measuring the fluorescence signal, the expression of luciferase can be determined, indirectly evaluating the effect of the ligand on the signaling pathway. The luciferase readout represents the activation level of the signaling pathway. Therefore, this cell line is widely used for the screening of BMP ligands, receptor agonists, or inhibitors, as well as for studying the regulatory mechanisms of the signaling pathway.
Data
Response to Recombinant Human, Mouse, Rat, Rhesus, Canine BMP-2 Protein. BRE Reporter 293 Cell Line (Cat. GM-C37665) at a concentration of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Recombinant BMP-2 Protein (Sino Biological/10426-HNAE) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). The maximum induction fold was approximately [8.9]. Data are shown by drug mass concentration.
Response to Anti-ACVR2B hIgG1 Antibody(Bimagrumab). Serial dilutions of the Anti-ACVR2B hIgG1 Antibody(Bimagrumab) (Cat. GM-51148AB) was incubated with 1.5E4 cells/well of the BRE Reporter 293 Cell Line (Cat. GM-C37665) in a 96-well plate for 1 hour in assay buffer (DMEM + 1% FBS + 1% P.S). Subsequently, the BMP-2 Protein (Sino Biological/10426-HNAE) at a concentration of 27 ng/well was added, and the coculture proceeded for an additional 6 hours. Firefly luciferase activity is then measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). The results indicated maximum blocking folds of approximately [2.9]. Data are shown by drug mass concentration.
The passage stability of response to Recombinant BMP-2 Protein. The passage 4, 14, and 24 of BRE Reporter 293 Cell Line (Cat. GM-C37665) at a concentration of 1.5E4 cells/well (96-well format) were stimulated with serial dilutions of Recombinant BMP-2 Protein (Sino Biological/10426-HNAE) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). Data are shown by drug mass concentration.
Response to ligand protein. The BRE Reporter 293 Cell Line (Cat. GGM-C37665) at a concentration of 1.5E4 cells/well (96-well format) was stimulated with serial dilutions of Human GDF-2 Protein (ACRO/GD2-H5211), Human Activin A Protein (Cat. GM-87616RP) and Human latent GDF-8 Protein(Cat. GM-87733RP) in assay buffer (DMEM+1% FBS+1% P.S) for 6 hours. The firefly luciferase activity was measured using the GMOne-Step Luciferase Reporter Gene Assay Kit (Cat. GM-040503). Data are shown by drug mass concentration.
BRE Reporter 293 Cell Line (Cat. GM-C37665) was determined by flow cytometry using Anti-ACVR2B hIgG1 Antibody(Bimagrumab) (Cat. GM-51148AB).
Specifications
Cat. NoGM-C37665
ProductBRE Reporter 293 Cell Line
Product Format1 vial of frozen cells
Quantity5E6 Cells per vail,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumDMEM+10% FBS+1% P.S
Growth mediumDMEM+10% FBS+1% P.S+4 μg/mL Blasticidin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesAdherent
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
DMEMGibco/C11995500BT
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
Blasticidin
Recombinant Human, Mouse, Rat, Rhesus, Canine BMP-2 ProteinSino Biological/10426-HNAE
Human GDF-2 Protein, Tag FreeACRO/GD2-H5211
Human Activin A Protein; His Tag
Human latent GDF-8 Protein; His Tag
Anti-ACVR2B hIgG1 Antibody(Bimagrumab)
GMOne-Step Luciferase Reporter Gene Assay Kit
Cell Culture

Cell Recovery

Recovery Medium: DMEM+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: DMEM+10% FBS+1% P.S+4 μg/mL Blasticidin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Subculturing is necessary when the cell density reaches 80%. It is recommended to perform subculturing at a ratio of 1:3 to 1:4 every 2-3 days. Ensure that the density does not exceed 80%, as overcrowding can lead to reduced viability due to compression.

b)         Remove and discard culture medium.

c)          Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

d)         Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 30 to 60 seconds at 37°C).

e)          Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

f)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

g)         After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

h)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:3 - 1:4 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          Upon initial thawing, a higher number of dead cells is observed, which is a normal phenomenon. Significant improvement is seen after adaptation. Once the cells reach a stable state, the number of dead cells decreases after subculturing and the cell growth rate becomes stable.

b)         Ensure that the cell density does not exceed 80%, as overcrowding may lead to reduced viability due to compression.

Related Products
Get A Quote
GCGR


GLP1R



FGF21:FGFR


CALCA(CGRP):CALCRL RAMP



GIP:GIPR




ACVR2A:ACTRIIB:Active A



AMY:CALCR RAMP

Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Message consultation
reset
submit
Service
Message
Message consultation
reset
submit
We use cookies and similar technologies on our website to enhance your experience and personalize content and ads. By continuing to use our website/app, you consent to the use of these technologies and the processing of your personal data for personalized and non-personalized advertising. By clicking 'Accept', you consent to the use of cookies and the processing of your data as described above